Recruiting Scleroderma Studies in Baltimore
About Scleroderma Clinical Trials in Baltimore
Scleroderma is an autoimmune connective tissue disease characterized by hardening and tightening of the skin and connective tissues. Systemic sclerosis can also affect internal organs including lungs, kidneys, and heart. Treatment is directed at specific symptoms and organ involvement.
There are currently 1 scleroderma clinical trials recruiting participants in Baltimore, MD. These studies are seeking a combined 30 participants. Research is being sponsored by Johns Hopkins University. Clinical trial participation is free and participants receive study-related medical care at no cost.
Scleroderma Clinical Trials in Baltimore — FAQ
Are there scleroderma clinical trials in Baltimore?
Yes, there are 1 scleroderma clinical trials currently recruiting in Baltimore, MD. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Baltimore?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Baltimore research site will contact you about next steps.
Are clinical trials in Baltimore free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Baltimore studies also compensate for your time and travel.
What scleroderma treatments are being tested?
The 1 active trials in Baltimore are testing new therapies including novel drugs, biologics, and treatment approaches for scleroderma.
Data updated March 2, 2026 from ClinicalTrials.gov